FMS - Company ID 0001333141
The table below shows Fresenius Medical Care AG's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|
| Revenue | $4.60B | $4.42B | $4.21B | $4.23B | $4.20B | - |
| Cost of revenue | $3.13B | $3.02B | $2.89B | $2.85B | $2.90B | $2.78B |
| Gross profit | $1.47B | $1.40B | $1.32B | $1.38B | $1.30B | $1.18B |
| R&D | $43.90M | $38.76M | $37.47M | $34.94M | $34.48M | $30.94M |
Fresenius Medical Care AG reported annual revenue of $5.27B for fiscal year 2014. That is up 5.9% from $4.97B in fiscal 2013. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $786.85M | $732.15M | $758.46M | $742.33M | $722.62M | $654.92M |
| Operating income | $669.94M | $641.09M | $540.29M | $613.53M | $546.96M | $504.40M |
| Income tax | $164.23M | $168.40M | $138.31M | $168.43M | $135.37M | $137.86M |
| Net income | $333.18M | $293.95M | $228.02M | $262.32M | $240.77M | $209.55M |
| EPS (diluted) | - | - | $0.75 | $0.86 | - | $0.69 |